NO142241B - PROCEDURE FOR PREPARING A STABLE, Aqueous SOLUTION FOR TOPICAL USE OF LIVING TISSUE - Google Patents
PROCEDURE FOR PREPARING A STABLE, Aqueous SOLUTION FOR TOPICAL USE OF LIVING TISSUE Download PDFInfo
- Publication number
- NO142241B NO142241B NO743385A NO743385A NO142241B NO 142241 B NO142241 B NO 142241B NO 743385 A NO743385 A NO 743385A NO 743385 A NO743385 A NO 743385A NO 142241 B NO142241 B NO 142241B
- Authority
- NO
- Norway
- Prior art keywords
- methyl
- mixture
- compound
- water
- solution
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- 239000007864 aqueous solution Substances 0.000 title description 14
- 230000000699 topical effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 24
- 239000001257 hydrogen Substances 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 14
- -1 arylalkyl halide Chemical class 0.000 claims description 12
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 150000002431 hydrogen Chemical class 0.000 claims description 7
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 239000012298 atmosphere Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 150000001350 alkyl halides Chemical class 0.000 claims description 2
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 66
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 52
- 239000000203 mixture Substances 0.000 description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 43
- 239000000243 solution Substances 0.000 description 34
- 239000000047 product Substances 0.000 description 30
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 23
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 18
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 16
- 238000001704 evaporation Methods 0.000 description 16
- 230000008020 evaporation Effects 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical group CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- 239000010410 layer Substances 0.000 description 11
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 9
- 235000019253 formic acid Nutrition 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 239000012299 nitrogen atmosphere Substances 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 150000003431 steroids Chemical class 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- 239000012312 sodium hydride Substances 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 5
- 150000004703 alkoxides Chemical class 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 5
- 239000000155 melt Substances 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- 239000001632 sodium acetate Substances 0.000 description 5
- 235000017281 sodium acetate Nutrition 0.000 description 5
- 239000012279 sodium borohydride Substances 0.000 description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 4
- 235000019799 monosodium phosphate Nutrition 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- FQHCPFMTXFJZJS-UHFFFAOYSA-N (4-methoxyphenyl)hydrazine;hydrochloride Chemical compound Cl.COC1=CC=C(NN)C=C1 FQHCPFMTXFJZJS-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 229930194542 Keto Natural products 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 2
- 229940067157 phenylhydrazine Drugs 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- FEKUXLUOKFSMRO-UHFFFAOYSA-N (4-fluorophenyl)hydrazine;hydron;chloride Chemical compound Cl.NNC1=CC=C(F)C=C1 FEKUXLUOKFSMRO-UHFFFAOYSA-N 0.000 description 1
- NOGFHTGYPKWWRX-UHFFFAOYSA-N 2,2,6,6-tetramethyloxan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)O1 NOGFHTGYPKWWRX-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000012435 aralkylating agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- WPUJEWVVTKLMQI-UHFFFAOYSA-N benzene;ethoxyethane Chemical compound CCOCC.C1=CC=CC=C1 WPUJEWVVTKLMQI-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- YWGHUJQYGPDNKT-UHFFFAOYSA-N hexanoyl chloride Chemical group CCCCCC(Cl)=O YWGHUJQYGPDNKT-UHFFFAOYSA-N 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical group CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Description
Fremgangsmåte ved fremstilling av 17a-hydroxy-20-oxo-4-pregnen-(3,2-c)-pyrazolforbindelser. Process for the production of 17a-hydroxy-20-oxo-4-pregnene-(3,2-c)-pyrazole compounds.
Foreliggende oppfinnelse angår en fremgangsmåte ved fremstilling av hittil ukjente 17a-hydroxy-20-oxo-4-pregnen-(3,2-c)-pyrazolforbindelser av en av de generelle formler: The present invention relates to a process for the production of hitherto unknown 17a-hydroxy-20-oxo-4-pregnene-(3,2-c)-pyrazole compounds of one of the general formulas:
hvor betegner g-hydroxy eller keto, R 2 betegner hydrogen, fluor eller methyl, R3 betegner a-methyl, Ø-methyl eller methylen, R4 betegner hydrogen eller acyl, Rg betegner hydrogen, acyl, alkyl, cycloalkyl, arylalkyl eller en arylgruppe som eventuelt kan være substituert med et halogenatom, en alkylgruppe eller en alkoxygrup-pe, og X betegner hydrogen eller halogen. where denotes g-hydroxy or keto, R 2 denotes hydrogen, fluorine or methyl, R3 denotes α-methyl, Ø-methyl or methylene, R4 denotes hydrogen or acyl, Rg denotes hydrogen, acyl, alkyl, cycloalkyl, arylalkyl or an aryl group which can optionally be substituted with a halogen atom, an alkyl group or an alkoxy group, and X denotes hydrogen or halogen.
De nye (3,2-c)-pyrazolsteroider har sterk antiinflamma-torisk virkning, betydelig sterkere enn modersteroidene, og de er spesielt effektive for behandling av arthritis og beslektede syk-dommer, da de gir en kortisonlignende virkning i små doser, hvorved uønskede bivirkninger holdes i sjakk. The new (3,2-c)-pyrazole steroids have a strong anti-inflammatory effect, significantly stronger than the parent steroids, and they are particularly effective for the treatment of arthritis and related diseases, as they produce a cortisone-like effect in small doses, whereby unwanted side effects are kept in check.
Fremgangsmåten ifølge oppfinnelsen for fremstilling av de nye (3,2-c)-pyrazolsteroider utmerker seg ved at en forbindelse av den generelle formel: The process according to the invention for the production of the new (3,2-c)-pyrazole steroids is distinguished by the fact that a compound of the general formula:
hvor R-^, Rj, R3 og X har de ovenfor angitte betydninger, omsettes med et alkylformiat og natriumhydrid i inert atmosfære, hvorved det fåes en forbindelse av den generelle formel: hvor R-p R 2> Rq °S X nar de ovenfor angitte betydninger, hvilken forbindelse omsettes i inert atmosfære med et hydrazin av den generelle formel R5NHNH2, hvor R,- har den ovenfor angitte betyd-ning, eller et salt derav, hvorved det fåes en forbindelse av en av de generelle formler: where R-^, Rj, R3 and X have the meanings given above, is reacted with an alkyl formate and sodium hydride in an inert atmosphere, whereby a compound of the general formula is obtained: where R-p R 2 > Rq °S X when the meanings given above, which compound is reacted in an inert atmosphere with a hydrazine of the general formula R5NHNH2, where R,- has the above meaning, or a salt thereof, whereby a compound of one of the general formulas is obtained:
hvor R-p R2) R3, R5 og X har de ovenfor angitte betydninger, hvilken forbindelse, dersom Rg er hydrogen, om ønskes omsettes med et acyleringsmiddel, et alkylhalogenid eller et arylalkylhalogenid, hvorved hydrogenet erstattes med en acyl-,' alkyl- eller arylalkyl-gruppe, hvorpå en eventuell 11-kétogruppe om ønskes reduseres til den tilsvarende ll(3-hydroxygruppe, hvoretter forbindelsen omsettes med en syre for avspaltning av methylendioxydgruppene, og den der- where R-p R2) R3, R5 and X have the meanings given above, which compound, if Rg is hydrogen, is, if desired, reacted with an acylating agent, an alkyl halide or an arylalkyl halide, whereby the hydrogen is replaced by an acyl-,' alkyl- or arylalkyl- group, whereupon a possible 11-keto group is, if desired, reduced to the corresponding 11(3-hydroxy group, after which the compound is reacted with an acid to remove the methylenedioxyd groups, and the
ved erholdte 21-hydroxyforbindelse om ønskes omdannes til en 2.1-ester ved omsetning med et acyleringsmiddel. with the resulting 21-hydroxy compound, if desired, is converted to a 2.1-ester by reaction with an acylating agent.
Omsetningen av det som utgangamateriale anvendte 17a,20,20,21-bis-(methylendioxy)-4-pregnen-3-on av formel II med alkylformiat og natriumhydrid i inert atmosfære utføres hensiktsmessig ved at man oppløser steroidet i et oppløsningsmiddel såsom benzen og avkjøler den dannede oppløsning til romtemperatur, hvoretter ethylformiat tilsettes. Luften i reaksjonsbeholderen skiftes ut med nitrogen, natriumhydrid tilsettes, og blandingen omrøres ved romtemperatur i flere timer. The reaction of the starting material 17a,20,20,21-bis-(methylenedioxy)-4-pregnen-3-one of formula II with alkyl formate and sodium hydride in an inert atmosphere is suitably carried out by dissolving the steroid in a solvent such as benzene and cools the resulting solution to room temperature, after which ethyl formate is added. The air in the reaction vessel is replaced with nitrogen, sodium hydride is added, and the mixture is stirred at room temperature for several hours.
For omsetning av 17a , 20 , 20 , 21-bis(methylendioxy)-2-hydroxymethylen-H-pregnen-3-onet av formel III med hydrazinforbindelsen er det hensiktsmessig å oppløse steroidet i absolutt ethanol og å oppvarme oppløsningen med hydrazinforbindelsen (eller et salt av denne forbindelse i nærvær av en buffer, såsom natriumacetat) i inert atmosfære. Dersom hydrazinforbindelsen er hydrazinhydrat, kan steroidoppløsningen med fordel tilsettes en 1:1-oppløsning av hydrazinhydrat og absolutt ethanol, hvoretter blandingen kokes under nitrogenatmosfære i ca. 4 5 minutter med tilbakeløpskjøling. I dette tilfelle fåes en forbindelse av formel IV hvor Rg er hydrogen. Dette hydrogen kan om ønskes skiftes ut ved å omsette forbindelsen med et alkylerings.middel, aralkyleringsmiddel eller acyleringsmiddel. Som acyleringsmiddel kan det hensiktsmessig anvendes benzoesyreanhydrid, tertiært butylacetylklorid, eddiksyreanhydrid, propionsyreanhydrid eller et polybasisk anhydrid, såsom 6,B-dimethylglutarsyreanhydrid eller ravsyreanhydrid. Acyleringen utføres hensiktsmessig i nærvær av en organisk base, såsom pyridin. For reaction of 17a , 20 , 20 , 21-bis(methylenedioxy)-2-hydroxymethylene-H-pregnen-3-one of formula III with the hydrazine compound, it is convenient to dissolve the steroid in absolute ethanol and to heat the solution with the hydrazine compound (or a salt of this compound in the presence of a buffer, such as sodium acetate) in an inert atmosphere. If the hydrazine compound is hydrazine hydrate, the steroid solution can advantageously be added to a 1:1 solution of hydrazine hydrate and absolute ethanol, after which the mixture is boiled under a nitrogen atmosphere for approx. 4 5 minutes with reflux cooling. In this case, a compound of formula IV is obtained where Rg is hydrogen. This hydrogen can, if desired, be replaced by reacting the compound with an alkylating agent, aralkylating agent or acylating agent. Benzoic anhydride, tertiary butyl acetyl chloride, acetic anhydride, propionic anhydride or a polybasic anhydride, such as 6,B-dimethylglutaric anhydride or succinic anhydride can be suitably used as an acylating agent. The acylation is conveniently carried out in the presence of an organic base, such as pyridine.
Reduksjon av et 11-ketoradikal i en erholdt forbindelse av en av formlene IV til den tilsvarende 11-3-hydroxygruppe kan utføres f.eks. ved å tilsette en mettet oppløsning av natriumborhydrid til en oppløsning av steroidet i en blanding av triethylamin og isopropanol, til hvilken blanding det foretrekkes å tilsette en liten mengde vann, og deretter la blandingen stå natten over. Reduction of an 11-keto radical in an obtained compound of one of the formulas IV to the corresponding 11-3-hydroxy group can be carried out e.g. by adding a saturated solution of sodium borohydride to a solution of the steroid in a mixture of triethylamine and isopropanol, to which mixture it is preferred to add a small amount of water, and then allowing the mixture to stand overnight.
Omsetningen av den erholdte forbindelse av en av formlene IV (etter eventuelle utskiftninger i 1'- eller 2'- og/eller 11-stillingen) med syre for avspaltning av methylendioxydgruppene kan foretaes f.eks. med en 60 % vandig oppløsning av maursyre. The reaction of the obtained compound of one of the formulas IV (after any substitutions in the 1'- or 2'- and/or 11-position) with acid to remove the methylenedioxide groups can be carried out, e.g. with a 60% aqueous solution of formic acid.
Ved reaksjonen fåes som regel en blanding av en 21-hydroxy og en 21-acyloxyforbindelse, hvor 21-acylgruppen stammer fra den organiske syre som anvendes ved reaksjonen. En blanding av steroidene inneholdende en 21-hydroxy- bg en 21-acyloxygruppe kan adskilles ved kromatografering. Eventuelle acylgrupper, som finnes ved R^ eller ved F, kan om ønskes fjernes ved behandling av steroidet med natriummethoxyd i methanol ved romtemperatur. The reaction usually results in a mixture of a 21-hydroxy and a 21-acyloxy compound, where the 21-acyl group originates from the organic acid used in the reaction. A mixture of the steroids containing a 21-hydroxy and a 21-acyloxy group can be separated by chromatography. Any acyl groups found at R^ or at F can, if desired, be removed by treating the steroid with sodium methoxide in methanol at room temperature.
Fremgangsmåten ifølge oppfinnelsen illustreres i de nedenstående eksempler. The method according to the invention is illustrated in the following examples.
Eksempel 1 Example 1
1,350 g 17a,20,20,21-bis(methylendioxy)-ll<g->hydroxy-16a-methyl-4-pregnen-3-on oppløses i 23 ml tørt, varmt benzen, og den dannede oppløsning avkjøles til romtemperatur og behandles med 0,96 ml friskt destillert ethylformiat. Luften i reaksjonsbeholderen fortrenges med nitrogen, og 560 mg natriumhydrid (som en 58 % dispersjon i mineralolje) tilsettes. Beholderen evakueres påny og fylles med nitrogen, og blandingen omrøres med magnetrører ved 1.350 g of 17a,20,20,21-bis(methylenedioxy)-1<g->hydroxy-16a-methyl-4-pregnen-3-one is dissolved in 23 ml of dry, hot benzene, and the resulting solution is cooled to room temperature and treated with 0.96 ml of freshly distilled ethyl formate. The air in the reaction vessel is displaced with nitrogen, and 560 mg of sodium hydride (as a 58% dispersion in mineral oil) is added. The container is evacuated again and filled with nitrogen, and the mixture is stirred with a magnetic stirrer
romtemperatur i 18 timer. Blandingen helles over i et overskudd av en mettet vandig oppløsning av natriumdihydrogenfosfat, og produktet ekstraheres 4 ganger med benzen. De organiske ekstrakter vaskes 3 ganger med vann og tørkes over natriumsulfat. Ved av-destillering av oppløsningsmidlet fåes det urene produkt, som opp-løses i ether og renses som natriumsaltet ved ekstraksjon med en 10 % oppløsning av natriumcarbonat. De vandige alkaliske ekstrakter gjøres atter sure med et overskudd av en mettet vandig oppløs-ning av natriumdihydrogenfosfat og ekstraheres med ether og med kloroform. De sammensatte organiske ekstrakter tørres over natrium-sulf at og inndampes til tørrhet, hvorved det fåes 850 mg 17a,20,20,21-bis(methylendioxy)-ll6-hydrozy-2-hydroxymethylen-16a-methyl-4-pregnen-3-on, som har følgende egenskaper: X ^^sian°"''= 249,8 my (e = 249), X maks = 307,5 mp (e = 100). room temperature for 18 hours. The mixture is poured into an excess of a saturated aqueous solution of sodium dihydrogen phosphate, and the product is extracted 4 times with benzene. The organic extracts are washed 3 times with water and dried over sodium sulfate. By distilling off the solvent, an impure product is obtained, which is dissolved in ether and purified as the sodium salt by extraction with a 10% solution of sodium carbonate. The aqueous alkaline extracts are made acidic again with an excess of a saturated aqueous solution of sodium dihydrogen phosphate and extracted with ether and with chloroform. The combined organic extracts are dried over sodium sulfate and evaporated to dryness, thereby obtaining 850 mg of 17a,20,20,21-bis(methylenedioxy)-116-hydrozy-2-hydroxymethylene-16a-methyl-4-pregnen-3 -on, which has the following properties: X ^^sian°"''= 249.8 my (e = 249), X max = 307.5 mp (e = 100).
Det dannede 17a,20,20,21-bis(methylendioxy)-llg-hydroxy-2-hydroxymethylen-16a-methyl-4-pregnen-3-on oppløses i 9,2 ml absolutt ethanol og behandles med en oppløsning av 0,16 ml hydrazinhydrat oppløst i 0,16 ml absolutt ethanol. Blandingen kokes med tilbakeløpskjøling i nitrogenatmosfære i ca. 4 5 minutter og inndampes deretter til tørrhet under forminsket trykk. Inndampningsresten vaskes 3 ganger med koldt vann, og det dannede amorfe stoff tørres ved 80° C i 1 time i kraftig vakuum, hvorved det fåes ca.-820 mg 17a,20,20,21-bis(methylendioxy)-16a-methyl-(3,2-c)-pyrazol- The formed 17a,20,20,21-bis(methylenedioxy)-llg-hydroxy-2-hydroxymethylene-16a-methyl-4-pregnen-3-one is dissolved in 9.2 ml of absolute ethanol and treated with a solution of 0, 16 ml hydrazine hydrate dissolved in 0.16 ml absolute ethanol. The mixture is boiled with reflux cooling in a nitrogen atmosphere for approx. 4 5 minutes and then evaporated to dryness under reduced pressure. The evaporation residue is washed 3 times with cold water, and the formed amorphous substance is dried at 80° C for 1 hour in a strong vacuum, whereby approx. 820 mg of 17a,20,20,21-bis(methylenedioxy)-16a-methyl- (3,2-c)-pyrazole-
4-pregnen-ll<g->ol, X maks = 261 my (e = 220). 4-pregnen-ll<g->ol, X max = 261 my (e = 220).
Til en oppløsning av 100 mg 17a,20,20,21-bis(methylen-dioxy)-16a-methyl-(3,2-c)-pyrazol-4-pregnen-llB-ol i 2 ml pyridin settes 0,5 ml eddiksyreanhydrid. Blandingen tillates å stå ved romtemperatur. En blanding av is og vann tilsettes deretter. Etter henstand i ca. 30 minutter ekstraheres produktet med ethylacetat. Ethylacetatekstrakten vaskes i rekkefølge med vann, iskold IN svovelsyre (inntil pH-verdien av vannsjiktet er 1 - 3), mettet vandig natriumhydrogencarbonat (inntil pH-verdien av vannsjiktet er 8), og vann (inntil vannsjiktet reagerer nøytralt). Ethylacetat-oppløsningen tørkes over vannfritt natriumsulfat. Derpå avdestilleres oppløsningsmidlet ved ca. 40° C i vakuum, hvorved man får 1' -acetyl-17a ,20 , 20, 21-bis-(methylend'ioxy )-16a-methyl- (3 , 2-c) - pyrazol-4-pregnen-llB-ol, som isoleres ved tilsetning av vann og filtrering. Add 0.5 ml of acetic anhydride. The mixture is allowed to stand at room temperature. A mixture of ice and water is then added. After a delay of approx. After 30 minutes, the product is extracted with ethyl acetate. The ethyl acetate extract is washed sequentially with water, ice-cold IN sulfuric acid (until the pH of the aqueous layer is 1 - 3), saturated aqueous sodium bicarbonate (until the pH of the aqueous layer is 8), and water (until the aqueous layer reacts neutrally). The ethyl acetate solution is dried over anhydrous sodium sulfate. The solvent is then distilled off at approx. 40° C in vacuum, whereby 1'-acetyl-17a,20,20,21-bis-(methylenedioxy)-16a-methyl-(3,2-c)-pyrazole-4-pregnen-11B- etc., which are isolated by adding water and filtering.
1'-acetyl-17a,20,20,21-bis(methylendioxy)-16a-methyl-(3,2-c)-pyrazol-4-pregnen-113-ol (720 mg) oppvarmes på dampbad med 24 ml av en 60 % vandig oppløsning av maursyre i ca. 30 minutter. Overskudd av reagens fjernes i vakuum under anvendelse av et vannbad av 50° C som varmekilde. Inndampningsresten skylles 4 ganger med n-hexan og tørkes deretter ved 6 0° C i kraftig vakuum, hvorved det fåes et amorft stoff, som er en blanding av 1'-acetyl-113,17a,21-trihydroxy-16a-methyl-(3,2-c)-pyrazol-4-pregnen-2o-on og 1'-acetyl-21-formyloxy-118,17a-dihydroxy-16a-methyl-(3,2-c)-pyrazol-4-pregnen-20-on, hvilke forbindelser adskilles ved kromatografering. 1'-acetyl-17a,20,20,21-bis(methylenedioxy)-16a-methyl-(3,2-c)-pyrazol-4-pregnen-113-ol (720 mg) is heated on a steam bath with 24 ml of a 60% aqueous solution of formic acid in approx. 30 minutes. Excess reagent is removed in vacuum using a water bath of 50° C as a heat source. The evaporation residue is rinsed 4 times with n-hexane and then dried at 60° C in a strong vacuum, whereby an amorphous substance is obtained, which is a mixture of 1'-acetyl-113,17a,21-trihydroxy-16a-methyl-( 3,2-c)-pyrazol-4-pregnen-2o-one and 1'-acetyl-21-formyloxy-118,17a-dihydroxy-16a-methyl-(3,2-c)-pyrazol-4-pregnen- 20-on, which compounds are separated by chromatography.
500 mg av dette urene produkt oppløses i 2,4 ml ren metha-.noi og tillates å stå og reagere med 0,9 ml av en 1,3 3 N oppløsning av natriummethoxyd i methanol ved romtemperatur under en nitrogenatmosfære i 10 minutter. Alkoxydet nøytraliseres med eddiksyre, 500 mg of this impure product is dissolved in 2.4 ml of pure methanol and allowed to stand and react with 0.9 ml of a 1.3 3 N solution of sodium methoxide in methanol at room temperature under a nitrogen atmosphere for 10 minutes. The alkoxide is neutralized with acetic acid,
og blandingen inndampes deretter til tørrhet og skylles med n-hexan. Inndampningsresten vaskes med vann, filtreres og tørkes til konstant vekt, hvorved det fåes ca. 375 mg 118,17a,21-trihydroxy-16a-methyl-(3,2-c) -pyrazol-4-pregnen-2o-on, X ^g^<01> = 263 my (£ = 233). and the mixture is then evaporated to dryness and rinsed with n-hexane. The evaporation residue is washed with water, filtered and dried to constant weight, whereby approx. 375 mg of 118,17a,21-trihydroxy-16a-methyl-(3,2-c)-pyrazol-4-pregnen-2o-one, X ^g^<01> = 263 my (£ = 233).
Eksempel 2 Example 2
2,60 g 17a,20,20,21-bis(methylendioxy)-9a-fluor-16a-methyl-4-pregnen-3,11-dion oppløses i 95 ml tørt benzen under anvendelse av tørr apparatur og behandles med 2,43 ml friskt destillert ethylformiat. Ca. 1,19 g av en dispersjon av natriumhydrid i 2.60 g of 17a,20,20,21-bis(methylenedioxy)-9a-fluoro-16a-methyl-4-pregnene-3,11-dione are dissolved in 95 ml of dry benzene using dry apparatus and treated with 2, 43 ml of freshly distilled ethyl formate. About. 1.19 g of a dispersion of sodium hydride i
mineralolje (ca. 51 %) tilsettes, etterfulgt av ca. 1,19 g friskt fremstilt tørt natriummethoxyd (tørket ved ca. 17 5° C med oljepumpe 1 4 timer). Luften i apparatet fortrenges påny med nitrogen, og blandingen,som straks blir gul, omrøres ved romtemperatur i 1 - mineral oil (approx. 51%) is added, followed by approx. 1.19 g freshly prepared dry sodium methoxide (dried at approx. 17 5° C with oil pump 1 4 hours). The air in the apparatus is again displaced with nitrogen, and the mixture, which immediately turns yellow, is stirred at room temperature for 1 -
1,5 timer. På dette tidspunkt er farven av reaksjonsblandingen mørk oransje. Blandingen avkjøles på isbad, og en kold, mettet oppløsning av natriumdihydrogenfosfat tilsettes gradvis for å spal-te overskudd av hydrid og for å nøytralisere alkoxydet. Ether tilsettes, og sjiktene skilles. De vandige sjikt ekstraheres tilbake med ether, og de sammenslåtte organiske sjikt vaskes syrefrie med vann og ekstraheres derpå 3-4 ganger med en 5 % vandig oppløsning av natriumhydrogencarbonat. Disse ekstrakter tillates å stå. Produktet ekstraheres deretter 4-5 ganger med en kold 2 % vandig oppløsning av natriumhydroxyd. For å unngå emulgering helles det vandige alkali forsiktig i skilletrakten, og sjiktene adskilles uten å ryste trakten. De to siste ekstrakter kan rystes med forsik-tighet. Den mørke væske ekstraheres tilbake to ganger med ether, og tilslutt surgjøres koldt med en mettet vandig oppløsning av natriumdihydrogenfosfat. Den nøytrale ether-benzen-fraksjon settes til side og behandles som beskrevet i det etterfølgende. Produktet ekstraheres med ether, og etherekstraktene vaskes syrefrie med en mettet oppløsning av natriumklorid. Etter tørking over magnesiumsulfat, inndampes etheroppløsningen til tørrhet, og det amorfe produkt omkrystalliseres fra methanol, hvorved det fåes 1,0 7 g (39 %) produkt med smeltepunkt 230 - 23 2° C, når smelte-punktsprøven oppvarmes fra 19 5° C. Stoffet er velegnet som ut-gangsmateriale ved de etterfølgende trinn. Den ultrafiolette absorpsjon i methanol inneholdende 2 % 2,5 N NaOH viser X ma^s <= >2 39 my (e = 342) og X maks = 360 my ( e = 213). Moderlutene gir et produkt av mindre renhet. En analytisk prøve av 17a , 20 , 20 , 21-bis-(methylendioxy)-9a-fluor-2-hydroxymethylen-16a-methyl-4-pregnen-3,11-dion, dannet ved omkrystallisasjon fra ether og fra methanol, gir et lavere smeltepunkt (221 - 224° C), men forbedrer den ultrafiolette absorpsjon (X <e>!r<n> = 239 my (e = 429), 359 , 5 my (e = 263)). 1.5 hours. At this point, the color of the reaction mixture is dark orange. The mixture is cooled in an ice bath, and a cold, saturated solution of sodium dihydrogen phosphate is gradually added to cleave excess hydride and to neutralize the alkoxide. Ether is added and the layers are separated. The aqueous layers are extracted back with ether, and the combined organic layers are washed acid-free with water and then extracted 3-4 times with a 5% aqueous solution of sodium bicarbonate. These extracts are allowed to stand. The product is then extracted 4-5 times with a cold 2% aqueous solution of sodium hydroxide. To avoid emulsification, the aqueous alkali is carefully poured into the separatory funnel, and the layers are separated without shaking the funnel. The last two extracts can be shaken with care. The dark liquid is extracted back twice with ether, and finally acidified cold with a saturated aqueous solution of sodium dihydrogen phosphate. The neutral ether-benzene fraction is set aside and treated as described below. The product is extracted with ether, and the ether extracts are washed acid-free with a saturated solution of sodium chloride. After drying over magnesium sulfate, the ether solution is evaporated to dryness, and the amorphous product is recrystallized from methanol, whereby 1.07 g (39%) of product with a melting point of 230 - 23 2° C is obtained, when the melting point sample is heated from 19 5° C The substance is suitable as a starting material for the subsequent steps. The ultraviolet absorption in methanol containing 2% 2.5 N NaOH shows X ma^s <= >2 39 my (e = 342) and X max = 360 my (e = 213). The mother liquors give a product of lower purity. An analytical sample of 17a , 20 , 20 , 21-bis-(methylenedioxy)-9a-fluoro-2-hydroxymethylene-16a-methyl-4-pregnene-3,11-dione, formed by recrystallization from ether and from methanol, gives a lower melting point (221 - 224° C), but improves the ultraviolet absorption (X <e>!r<n> = 239 my (e = 429), 359 , 5 my (e = 263)).
JIlclXS JIlclXS
1,00 g 17a,20,20,21-bis(methylendioxy)-9a-fluor-2-hydroxymethylen-16a-methyl-4-pregnen-3,ll-dion (smeltepunkt 230 - 232° C) suspenderes i 44 ml absolutt ethanol og behandles med 0,38 ml hydrazinhydrat (99 - 100 %). Luften i apparatet fortrenges med nitrogen, og blandingen oppvarmes hurtig til kokepunktet. Etter kokning i 1 time med tilbakeløpskjøling inndampes blandingen til 1.00 g of 17a,20,20,21-bis(methylenedioxy)-9a-fluoro-2-hydroxymethylene-16a-methyl-4-pregnen-3,11-dione (melting point 230 - 232° C) is suspended in 44 ml absolute ethanol and treated with 0.38 ml of hydrazine hydrate (99 - 100%). The air in the apparatus is displaced with nitrogen, and the mixture is rapidly heated to the boiling point. After boiling for 1 hour with reflux cooling, the mixture is further evaporated
tørrhet. Den oljeaktige inndampningsrest behandles med vann, og det amorfe stoff fjernes ved filtrering, vaskes omhyggelig med vann og tørkes. Utbyttet er ca. 900 ml. Råproduktet oppløses i absolutt ethanol og konsentreres i vakuum, inntil fast stoff utskilles. Dette stoff oppløses påny ved oppvarming, og det settes tilside for langsom utkrystallisering, hvorved det fåes 700 mg 17a,20,20,21-bis(methylendioxy)-9a-fluor-16a-methyl-(3,2-c)-pyra- dryness. The oily evaporation residue is treated with water, and the amorphous material is removed by filtration, washed thoroughly with water and dried. The yield is approx. 900 ml. The crude product is dissolved in absolute ethanol and concentrated in vacuo, until a solid is separated. This substance is redissolved by heating and set aside for slow crystallization, whereby 700 mg of 17a,20,20,21-bis(methylenedioxy)-9a-fluoro-16a-methyl-(3,2-c)-pyra is obtained -
PH DH PH DH
zol-4-pregnen-ll-on, X = 260 my (e = 215). Stoffet smelter over 300° C. zol-4-pregnen-ll-one, X = 260 my (e = 215). The substance melts above 300°C.
455 mg 17a,20,20,21-bis(methylendioxy)-9a-fluor-16a-methyl-(3,2-c)-pyrazol-4-pregnen-ll-on suspenderes i 75 ml av en oppløsning av natriumborhydrid i isopropanol, som fremstilles ved oppslemming av et overskudd av natriumborhydrid i isopropanol, kraftig omrøring i ca. 15 minutter og filtrering for fraskillelse av overskudd av natriumborhydrid. Til suspensjonen settes 0,816 ml av en oppløsning av 0,55 ml triethylamin i 1,45 ml isopropanol. Blandingen omrøres, og det tilsettes så meget methylenklorid (ca. 455 mg of 17a,20,20,21-bis(methylenedioxy)-9a-fluoro-16a-methyl-(3,2-c)-pyrazol-4-pregnen-11-one are suspended in 75 ml of a solution of sodium borohydride in isopropanol, which is produced by slurrying an excess of sodium borohydride in isopropanol, vigorous stirring for approx. 15 minutes and filtration to separate excess sodium borohydride. 0.816 ml of a solution of 0.55 ml of triethylamine in 1.45 ml of isopropanol is added to the suspension. The mixture is stirred, and as much methylene chloride is added (approx.
3 0 ml) under avkjøling at blandingen blir homogen. En vanndråpe (ca. 1/20 ml) tilsettes, og blandingen omrøres i nitrogenatmosfære ved romtemperatur i 18 timer. Det utskilles vanligvis noe uopp-løselig stoff under reaksjonen. Derpå avkjøles blandingen, og overskudd av natriumborhydrid spaltes ved tilsetning av kold 2,5 N saltsyre. Blandingen (pH ca. 5) inndampes til tørrhet i vakuum og inndampingsresten vaskes med vann og tørres, hvorved det fåes 42 5 mg 17a,20,20,21-bis(methylendioxy)-9a-fluor-llg-hydroxy-16a-methyl-(3,2-c)-pyrazol-4-pregnen, som ikke viser noen mettet carbonylab-sorpsjon i det infrarøde område (Nujol). Smeltepunkt 240° C under spaltning. Hydrogenkloridet karakteriseres ytterligere ved en hydrogenbinding (3,5 - 4,5 y) og ved skarpe maksima ved 6,1 y og 6,2 7 y. Hydrogenkloridet er uoppløselig i vann og i methylenklorid. (I nærvær av begge oppløsningsmidler hydrolyserer saltet og gir det frie amin, som er uoppløselig i methylenklorid). Den ultrafiolette absorpsjon av hydrogenkloridet viser X CH 3 OH= 265 my 30 ml) while cooling so that the mixture becomes homogeneous. A drop of water (approx. 1/20 ml) is added, and the mixture is stirred in a nitrogen atmosphere at room temperature for 18 hours. Some insoluble substance is usually excreted during the reaction. The mixture is then cooled, and excess sodium borohydride is decomposed by adding cold 2.5 N hydrochloric acid. The mixture (pH approx. 5) is evaporated to dryness in a vacuum and the evaporation residue is washed with water and dried, thereby obtaining 42 5 mg of 17a,20,20,21-bis(methylenedioxy)-9a-fluoro-IIg-hydroxy-16a-methyl -(3,2-c)-pyrazole-4-pregnene, which shows no saturated carbonylab sorption in the infrared region (Nujol). Melting point 240° C during decomposition. The hydrogen chloride is further characterized by a hydrogen bond (3.5 - 4.5 y) and by sharp maxima at 6.1 y and 6.2 7 y. The hydrogen chloride is insoluble in water and in methylene chloride. (In the presence of both solvents, the salt hydrolyzes to give the free amine, which is insoluble in methylene chloride). The ultraviolet absorption of the hydrogen chloride shows X CH 3 OH= 265 my
m^t-K s m^t-K p
(e = 208). Produktet forkulles ved ca. 273° C. Analyse for klor: Beregnet 7,14 %; funnet: 7,14 %. (e = 208). The product chars at approx. 273° C. Analysis for chlorine: Calculated 7.14%; found: 7.14%.
Til en oppløsning av 100 mg 17a,20,20,21-bis(methylen-dioxy)-9a-fluor-ll8-hydroxy-16a-methyl-(3,2-c)-pyrazol-4-pregnen i 2 ml pyridin settes 0,5 ml eddiksyreanhydrid. Blandingen tillates å stå i 18 timer ved romtemperatur. En blanding av is og vann tilsettes deretter. Etter henstand i ca. 30 minutter ekstraheres produktet med ethylacetat. Ethylacetatekstrakten vaskes i rekke-følge med vann, iskold 1 N svovelsyre (inntil pH-verdien av vannsjiktet er 1 - 3), mettet vandig natriumhydrogencarbonat (inntil pH-verdien av vannsjiktet er 8), og vann (inntil vannsjiktet reagerer nøytralt). Ethylacetatet avdestilleres deretter ved ca. To a solution of 100 mg of 17a,20,20,21-bis(methylene-dioxy)-9a-fluoro-118-hydroxy-16a-methyl-(3,2-c)-pyrazole-4-pregnene in 2 ml of pyridine add 0.5 ml of acetic anhydride. The mixture is allowed to stand for 18 hours at room temperature. A mixture of ice and water is then added. After a delay of approx. After 30 minutes, the product is extracted with ethyl acetate. The ethyl acetate extract is washed sequentially with water, ice-cold 1 N sulfuric acid (until the pH of the aqueous layer is 1 - 3), saturated aqueous sodium bicarbonate (until the pH of the aqueous layer is 8), and water (until the aqueous layer reacts neutrally). The ethyl acetate is then distilled off at approx.
40° C i vakuum, hvorved det fåes 1'-acetyl-17a,20,20,21-bis(methy-lendioxy)-9a-fluor-118-hydroxy-16a-methyl-(3,2-c)-pyrazol-4-pregnen, som isoleres ved tilsetning av vann og filtrering. 40° C in vacuum, whereby 1'-acetyl-17a,20,20,21-bis(methylenedioxy)-9a-fluoro-118-hydroxy-16a-methyl-(3,2-c)-pyrazole is obtained -4-pregnene, which is isolated by adding water and filtering.
1'-acetyl-17a,20,2 0,21-bis-(methylendioxy)-9a-fluor-116-hydroxy-16a-methyl-(3,2-c)-pyrazol-4-pregnen (25 mg) oppvarmes på dampbad med 6 ml av en 50 % vandig oppløsning av maursyre i ca. 3 0 minutter. Overskudd av reagens fjernes under redusert trykk på vannbad ved ca. 50° C. Inndampningsresten skylles med n-hexan. Deretter oppløses inndampningsresten i aceton og utfelles med n-hexan, hvorved det fåes en amorf blanding av 9a-fluor-113,17a,21-trihydroxy-16a-methyl- (3 , 2-c) -pyrazol-4-pregnen-20 -on og 11 -acetyl-9a-fluor-21-formyloxy- 116,17a-dihydroxy-16a-methyl-(3,2-c)-pyra-zol-4-pregnen-20-on, hvilke forbindelser adskilles ved kromatografering. 1'-Acetyl-17a,20,20,21-bis-(methylenedioxy)-9a-fluoro-116-hydroxy-16a-methyl-(3,2-c)-pyrazole-4-pregnene (25 mg) is heated on a steam bath with 6 ml of a 50% aqueous solution of formic acid for approx. 30 minutes. Excess reagent is removed under reduced pressure in a water bath at approx. 50° C. The evaporation residue is rinsed with n-hexane. The evaporation residue is then dissolved in acetone and precipitated with n-hexane, whereby an amorphous mixture of 9a-fluoro-113,17a,21-trihydroxy-16a-methyl-(3,2-c)-pyrazole-4-pregnene-20 is obtained -one and 11 -acetyl-9a-fluoro-21-formyloxy-116,17a-dihydroxy-16a-methyl-(3,2-c)-pyrazol-4-pregnen-20-one, which compounds are separated by chromatography .
500 mg av dette råprodukt oppløses i 2,4 ml ren methanol og omsettes med 0,9 ml av en 1,33 N oppløsning av natriummethoxyd i methanol ved romtemperatur under nitrogenatmosfære i 10 minutter. Alkoxydet nøytraliseres med eddiksyre, og blandingen inndampes deretter til tørrhet, filtreres og tørkes til konstant vekt til 9a-fluor-118,17a,21-trihydroxy-16a-methyl-(3,2-c)-pyrazol-4-pregnen-20-on. Hydrokloridet smelter ved 300° C under spaltning. 500 mg of this crude product is dissolved in 2.4 ml of pure methanol and reacted with 0.9 ml of a 1.33 N solution of sodium methoxide in methanol at room temperature under a nitrogen atmosphere for 10 minutes. The alkoxide is neutralized with acetic acid, and the mixture is then evaporated to dryness, filtered and dried to constant weight to 9α-fluoro-118,17α,21-trihydroxy-16α-methyl-(3,2-c)-pyrazole-4-pregnene-20 -on. The hydrochloride melts at 300° C during decomposition.
Eksempel 3 Example 3
Ca. 6 g 17a,20,20,21-bis(methylendioxy)-116-hydroxy-16a-methyl-4-pregnen-3-on suspenderes i ca. 35 ml tørt benzen, og til denne suspensjon settes 6 ml ethylformiat og ca. lg friskt fremstilt natriummethoxyd. Blandingen tillates å stå ved romtemperatur under nitrogen i 1 - i time og avkjøles deretter på isbad. Deretter gjøres blandingen sur med et overskudd av en mettet vandig oppløsning av kaliumdihydrogenfosfat. Ether tilsettes, og produktet ekstraheres flere ganger med en vandig oppløsning av natriumhydroxyd. Ekstraktene ekstraheres tilbake med ether, det surgjøres med kold 2,5 N HC1 og ekstraheres deretter med methylenklorid. Methylenkloridekstraktene vaskes med vandig mettet natriumkloridoppløsning, tørres over raagnesiumsulfat og inndampes deretter til tørrhet. Det dannede skum gir en kraftig ferriklorid-reaksjon og omkrystalliseres med ether-petrolether, hvorved 17a, 20 ,2 0 , 21-bis(methylendioxy)-118-formyloxy-2-hydroxymethylen-16a-methyl-4-pregnen-3-on fåes. Denne forbindelse oppviser infra-røde absorpsjonsegenskaper svarende til A-ring-hydroxymethylen, hvilken struktur er i overensstemmelse med den ultrafiolette absorpsjon i alkalisk methanol, X CH 3 OH= 242 my og 357 my. Enn-videre oppviser forbindelsen et kraftig maksimum i det infrarøde område ved 5,84 - 5,85 my og likeledes ved 8,5 my. Disse maksima er karakteristiske for 11 -formiat. About. 6 g of 17a,20,20,21-bis(methylenedioxy)-116-hydroxy-16a-methyl-4-pregnen-3-one is suspended for approx. 35 ml of dry benzene, and to this suspension add 6 ml of ethyl formate and approx. lg freshly prepared sodium methoxide. The mixture is allowed to stand at room temperature under nitrogen for 1-1 hour and then cooled in an ice bath. The mixture is then acidified with an excess of a saturated aqueous solution of potassium dihydrogen phosphate. Ether is added, and the product is extracted several times with an aqueous solution of sodium hydroxide. The extracts are extracted back with ether, acidified with cold 2.5 N HCl and then extracted with methylene chloride. The methylene chloride extracts are washed with aqueous saturated sodium chloride solution, dried over magnesium sulfate and then evaporated to dryness. The foam formed gives a strong ferric chloride reaction and is recrystallized with ether-petroleum ether, whereby 17a, 20 , 2 0 , 21-bis(methylenedioxy)-118-formyloxy-2-hydroxymethylene-16a-methyl-4-pregnen-3-one can be obtained. This compound exhibits infrared absorption properties corresponding to A-ring hydroxymethylene, which structure is in agreement with the ultraviolet absorption in alkaline methanol, X CH 3 OH= 242 my and 357 my. Furthermore, the compound shows a strong maximum in the infrared region at 5.84 - 5.85 my and likewise at 8.5 my. These maxima are characteristic of 11 -formate.
Til 1,433 g 17a,20,20,21-bis(methylendioxy)-llB-formyl-oxy-2-hydroxymethylen-16a-methyl-4-pregnen-3-on, suspendert i 18 To 1.433 g of 17a,20,20,21-bis(methylenedioxy)-11B-formyl-oxy-2-hydroxymethylene-16a-methyl-4-pregnen-3-one, suspended in 18
ml absolutt ethanol, settes 0,45 ml fenylhydrazin, og blandingen kokes med tilbakeløpskjøling i 40 minutter under nitrogen. Ved avkjøling utfelles 17a,20,20,21-bis(methylendioxy)-lla-formyloxy-16a-methyl-l'-fenyl-(3,2-c)-pyrazol-4-pregnen. ml of absolute ethanol, 0.45 ml of phenylhydrazine is added, and the mixture is refluxed for 40 minutes under nitrogen. On cooling, 17a,20,20,21-bis(methylenedioxy)-11a-formyloxy-16a-methyl-1'-phenyl-(3,2-c)-pyrazole-4-pregnene precipitates.
17a,20,20,21-bis(methylendioxy)-llB-formyloxy-16a-methyl-1'-fenyl-(3,2-c)-pyrazol-4-pregnen (720 mg) oppvarmes på dampbad med 24 ml 60 % vandig oppløsning av maursyre i ca. 30 minutter. Overskudd av reagenset avdestilleres i vakuum på vannbad ved ca. 50° C. Inndampningsresten skylles 4 ganger med n-hexan og tørres deretter ved 60° C i kraftig vakuum, hvorved det fåes en fast blanding av 113,17a,21-trihydroxy-16a-methyl-l'-fenyl-(3,2-c) -pyrazol-4-pregnen-20-on og 118>17a,21-trihydroxy-16a-methyl-l'-fenyl-(3,2-c) -pyrazol-4-pregnen-2 0-on-formiat. 17a,20,20,21-bis(methylenedioxy)-11B-formyloxy-16a-methyl-1'-phenyl-(3,2-c)-pyrazole-4-pregnene (720 mg) is heated on a steam bath with 24 ml 60 % aqueous solution of formic acid in approx. 30 minutes. The excess of the reagent is distilled off in a vacuum on a water bath at approx. 50° C. The evaporation residue is rinsed 4 times with n-hexane and then dried at 60° C in a strong vacuum, whereby a solid mixture of 113,17a,21-trihydroxy-16a-methyl-1'-phenyl-(3, 2-c)-pyrazol-4-pregnen-20-one and 118>17a,21-trihydroxy-16a-methyl-1'-phenyl-(3,2-c)-pyrazol-4-pregnen-20-one - format.
500 mg av dette råprodukt oppløses i 2,4 ml rent methanol og bringes til å reagere med 0,9 ml av en 1,3 3 N oppløsning av natriummethoxyd i methanol ved romtemperatur under nitrogenatmosfære i 10 minutter. Dette alkoxyd nøytraliseres med eddiksyre, og blandingen inndampes til tørrhet og skylles med n-hexan. Inndampingsresten vaskes med vann, filtreres og tørkes til konstant vekt, hvorved fåes 118,17a,2l-trihydroxy-16a-methyl-l'-fenyl-(3,2-c) - pyrazol-4-pregnen-20-on. Forbindelsen isomeriseres til 2'-forbindelsen ved omdannelse til hydrokloridet som smelter ved 14 3 - 14 5°C. 500 mg of this crude product is dissolved in 2.4 ml of pure methanol and reacted with 0.9 ml of a 1.3 3 N solution of sodium methoxide in methanol at room temperature under a nitrogen atmosphere for 10 minutes. This alkoxide is neutralized with acetic acid, and the mixture is evaporated to dryness and rinsed with n-hexane. The evaporation residue is washed with water, filtered and dried to constant weight, whereby 118,17a,2l-trihydroxy-16a-methyl-1'-phenyl-(3,2-c)-pyrazol-4-pregnen-20-one is obtained. The compound is isomerized to the 2' compound by conversion to the hydrochloride which melts at 14 3 - 14 5°C.
Eksempel 4 Example 4
Til 200 mg 17a,20,20,21-bis(methylendioxy)-ll8-hydroxy-2-hydroxymethylen-16a-methyl-4-pregnen-3-on, fremstilt som beskre- To 200 mg of 17a,20,20,21-bis(methylenedioxy)-ll8-hydroxy-2-hydroxymethylene-16a-methyl-4-pregnen-3-one, prepared as described
vet i eksempel 1, i 7 ml absolutt ethanol, settes 82 mg natrium- know in example 1, in 7 ml of absolute ethanol, put 82 mg of sodium
acetat og derpå 102 mg cyclohexylhydrazinoxalat. Blandingen kokes under nitrogen i 1 time. Uoppløselig materiale fjernes ved filtrering. Filtratet inndampes til tørrhet. Inndampningsresten opp- acetate and then 102 mg of cyclohexylhydrazinoxalate. The mixture is boiled under nitrogen for 1 hour. Insoluble material is removed by filtration. The filtrate is evaporated to dryness. The evaporation residue up-
løses i 3 ml ether, og etheroppløsningen vaskes i rekkefølge med 2 % vandig natriumhydroxyd og derpå med vann til nøytral reaksjon. Etheroppløsningen tørkes deretter over magnesiumsulfat, filtreres is dissolved in 3 ml of ether, and the ether solution is washed successively with 2% aqueous sodium hydroxide and then with water to a neutral reaction. The ether solution is then dried over magnesium sulfate, filtered
og inndampes til tørrhet, hvorved det fåes 19 7,7 mg av et gult stoff bestående av 17a,20,20,21-bis(methylendioxy)-1'-cyclohexyl-16a-methyl-(3,2-c) -pyrazol-4-pregnen-llB-ol, X maks = 273 my (e = 165). and evaporated to dryness, thereby obtaining 19 7.7 mg of a yellow substance consisting of 17a,20,20,21-bis(methylenedioxy)-1'-cyclohexyl-16a-methyl-(3,2-c)-pyrazole -4-pregnen-11B-ol, X max = 273 my (e = 165).
150 mg av det ovennevnte stoff oppvarmes under nitrogen 150 mg of the above substance is heated under nitrogen
med 5 ml av en 60 % vandig oppløsning av maursyre i ca. 40 minutter. Bladningen inndampes til tørrhet, og deretter tilsettes vann. Produktet ekstraheres med kloroform, og kloroformoppløsningen vaskes med mettet vandig natriumkloridoppløsning, 5 % vandig natriumhydro-gencarbonatoppløsning og derpå med vann. Kloroformoppløsningen tørkes over magnesiumsulfat og inndampes til tørrhet, hvorved det fåes en inndampningsrest på 7'6 mg. Denne taes opp i ether inneholdende litt methanol, omrøres med 75 mg aktivkull, filtreres og inndampes deretter til tørrhet, hvorved fåes lip,17a,21-trihydroxy-16a-methyl-l' -cyclohexyl-(3 , 2-c) -pyrazol-4-pregnen-20-on, X ma]<s = with 5 ml of a 60% aqueous solution of formic acid for approx. 40 minutes. The leaves are evaporated to dryness, and then water is added. The product is extracted with chloroform, and the chloroform solution is washed with saturated aqueous sodium chloride solution, 5% aqueous sodium hydrogencarbonate solution and then with water. The chloroform solution is dried over magnesium sulphate and evaporated to dryness, whereby an evaporation residue of 7.6 mg is obtained. This is taken up in ether containing a little methanol, stirred with 75 mg of activated charcoal, filtered and then evaporated to dryness, whereby lip,17a,21-trihydroxy-16a-methyl-1'-cyclohexyl-(3,2-c)-pyrazole is obtained -4-pregnen-20-on, X ma]<s =
276 my (e = 199). 276 my (e = 199).
Eksempel 5 Example 5
En blanding av 90 mg 17a,20,20,21-bisCmethylendioxy)-ll6-hydroxy-2-hydroxymethylen-16a-methyl-4-pregnen-3-on 5 fremstilt som beskrevet i eksempel 1, og 0,028 ml fenylhydrazin kokes under nitrogen i 1,2 ml absolutt ethanol i 50 minutter. Reaksjonsblandingen inndampes til tørrhet. Vann tilsettes, og produktet frafiltreres som et amorft stoff som vaskes i rekkefølge med vann, fortynnet syre, vann og petrolether. Produktet omkrystalliseres fra methanol, hvorved det fåes 17a>20,20,21-bis(methylendioxy)-116-hydroxy-16a-methyl-l' -f enyl-(3 , 2-c) -pyrazol-4-pregnen, X ma;ks = A mixture of 90 mg of 17α,20,20,21-bisCmethylenedioxy)-116-hydroxy-2-hydroxymethylene-16α-methyl-4-pregnen-3-one 5 prepared as described in Example 1, and 0.028 ml of phenylhydrazine is boiled under nitrogen in 1.2 ml of absolute ethanol for 50 minutes. The reaction mixture is evaporated to dryness. Water is added, and the product is filtered off as an amorphous substance which is washed successively with water, dilute acid, water and petroleum ether. The product is recrystallized from methanol, whereby 17a>20,20,21-bis(methylenedioxy)-116-hydroxy-16a-methyl-1'-phenyl-(3,2-c)-pyrazole-4-pregnene is obtained, X ma;ks =
260 my (e = 308). 260 my (e = 308).
30 mg av dette produkt oppvarmes på dampbad med 2 ml 30 mg of this product is heated on a steam bath with 2 ml
60 % maursyre i 35 minutter. Oppløsningsmidlene avdestilleres i 60% formic acid for 35 minutes. The solvents are distilled off in
vakuum, hvorpå det tilsettes vann, og produktet filtreres, hvorved det fåes en blanding av 116,17a,21-trihydroxy-16a-methyl-l'-fenyl-(3,2-c)-pyrazol-4-pregnen-20-on og 21-formiatet av dette. Til-stedeværelsen av formiat fremgår av den infrarøde absorpsjon ved 5,81 og 8,5 y. vacuum, whereupon water is added, and the product is filtered, whereby a mixture of 116,17a,21-trihydroxy-16a-methyl-1'-phenyl-(3,2-c)-pyrazole-4-pregnene-20- on and the 21 format of this. The presence of formate is evident from the infrared absorption at 5.81 and 8.5 y.
500 mg av dette råprodukt oppløses i 2,4 ml ren methanol og omsettes med 0,9 ml av en 1,3 3 N oppløsning av natriummethoxyd i methanol ved romtemperatur under nitrogenatmosfære i 10 minutter. Alkoxydet nøytraliseres med eddiksyre, og blandingen inndampes til tørrhet og skylles med n-hexan. Inndampningsresten vaskes med vann, filtreres og tørres til konstant vekt, hvorved fåes 116,17a,21-trihydroxy-16a-methyl-l'-fenyl-(3,2-c)-pyrazol-4-preg-nen-20-on, X ma^g3 = 2,8 - 3,0 y, 5,84 y, 6,13 y, 6,21 y og 6,61 y. 500 mg of this crude product is dissolved in 2.4 ml of pure methanol and reacted with 0.9 ml of a 1.3 3 N solution of sodium methoxide in methanol at room temperature under a nitrogen atmosphere for 10 minutes. The alkoxide is neutralized with acetic acid, and the mixture is evaporated to dryness and rinsed with n-hexane. The evaporation residue is washed with water, filtered and dried to constant weight, whereby 116,17a,21-trihydroxy-16a-methyl-1'-phenyl-(3,2-c)-pyrazol-4-preg-nen-20-one is obtained , X ma^g3 = 2.8 - 3.0 y, 5.84 y, 6.13 y, 6.21 y and 6.61 y.
Eksempel 6 Example 6
Til en blanding av 223 mg 17a,20,20,21-bis(methylen-dioxy)-116-hydroxy-2-hydroxymethylen-16a-methylen-4-pregnen-3-on, fremstilt som beskrevet i eksempel 1, i 5 ml absolutt ethanol, settes 49 mg natriumacetat og derpå 95 mg p-toylhydrazinhydrogen-klorid. Blandingen kokes med tilbakeløpskjøling under nitrogen i 45 minutter. Etter avkjøling utfelles et fast stoff som frafiltreres. Filtratet inndampes til tørrhet, og det tilsettes vann. Produktet filtreres, vaskes med vann, fortynnet syre og påny med vann, inntil reaksjonen er nøytral, hvorved fåes 17a,20,20,21-bis-(methylendioxy)-16a-methyl-l'-(p-tolyl)-(3,2-c)-pyrazol-4-pregnen-II6-0I, X maks 262,5 my, (e = 276). To a mixture of 223 mg of 17a,20,20,21-bis(methylene-dioxy)-116-hydroxy-2-hydroxymethylene-16a-methylene-4-pregnen-3-one, prepared as described in Example 1, in 5 ml of absolute ethanol, add 49 mg of sodium acetate and then 95 mg of p-toylhydrazine hydrogen chloride. The mixture is refluxed under nitrogen for 45 minutes. After cooling, a solid is precipitated which is filtered off. The filtrate is evaporated to dryness, and water is added. The product is filtered, washed with water, dilute acid and again with water, until the reaction is neutral, whereby 17a,20,20,21-bis-(methylenedioxy)-16a-methyl-1'-(p-tolyl)-(3 ,2-c)-pyrazole-4-pregnene-II6-0I, X max 262.5 my, (e = 276).
Produktet renses ved oppløsning av 2 35 mg av det urene materiale i 30 ml methanol og omrøring ved romtemperatur med 2 35 mg aktivkull. Produktet filtreres, og filtratet konsentreres og omkrystalliseres, hvorved fåes 17a,20,20,21-bis(methylendioxy)-16a-methyl-1'-(p-tolyl)-(3,2-c)-pyrazol-4-pregnen-ll-ol, smeltepunkt 161 - 163,5° C, U.V. X , 263 my, (e = 329); I.R. 3 y område, 6,15 y, 6,55 y, 9,06 y. 13 mg av ovennevnte produkt oppvarmes på dampbad med 1 ml av en 6 0 % vandig oppløsning av maursyre i ca. 3 5 minutter. Blandingen inndampes til tørrhet, det tilsettes vann, og produktet fra filtreres, hvorved fåes 116,17a,21-trihydroxy-16a-methyl-l'-(p-tolyl)-(3,2-c)-pyrazol-4-pregnen-20-on, I.R. 2,74 y, 2,8 til 3,0 y, The product is purified by dissolving 2 35 mg of the impure material in 30 ml of methanol and stirring at room temperature with 2 35 mg of activated carbon. The product is filtered, and the filtrate is concentrated and recrystallized, whereby 17a,20,20,21-bis(methylenedioxy)-16a-methyl-1'-(p-tolyl)-(3,2-c)-pyrazole-4-pregnene is obtained -ll-ol, melting point 161 - 163.5° C, U.V. X , 263 my, (e = 329); I.R. 3 y area, 6.15 y, 6.55 y, 9.06 y. 13 mg of the above product is heated on a steam bath with 1 ml of a 60% aqueous solution of formic acid in approx. 3 5 minutes. The mixture is evaporated to dryness, water is added, and the product from filtered, whereby 116,17a,21-trihydroxy-16a-methyl-1'-(p-tolyl)-(3,2-c)-pyrazol-4-pregnen-20-one is obtained, I.R. 2.74 y, 2.8 to 3.0 y,
5,82 y, 6,1 til 6,55 y; U.V. A maks 265 my, (e =355). 5.82 y, 6.1 to 6.55 y; UV A max 265 my, (e =355).
Eksempel 7 Example 7
111,5 mg 17a,20,20,21-bis(methylendioxy)-116-hydroxy-2-hydroxymethylen-16a-methyl-4-pregnen-3-on, fremstilt som beskrevet i eksempel 1, suspenderes i 2,5 ml ethanol og behandles med 24,5 mg natriumacetat, hvoretter det tilsettes 48,5 mg p-fluor-fenyl-hydrazin-hydrogenklorid. Luften i beholderen fortrenges med nitrogen, 111.5 mg of 17a,20,20,21-bis(methylenedioxy)-116-hydroxy-2-hydroxymethylene-16a-methyl-4-pregnen-3-one, prepared as described in example 1, is suspended in 2.5 ml ethanol and treated with 24.5 mg of sodium acetate, after which 48.5 mg of p-fluoro-phenyl-hydrazine hydrogen chloride is added. The air in the container is displaced with nitrogen,
og blandingen oppvarmes hurtig til kokepunktet. Etter kokning med tilbakeløpskjøling i 1 time inndampes blandingen til tørrhet. Inndampningsresten oppløses i ether, ethersjiktet behandles 3 ganger med 2,5 N saltsyre og deretter 3 ganger med 2,5 N natriumhydroxyd og tilslutt med vann. Ethersjiktet tørkes over magnesiumsulfat, filtreres og konsentreres til tørrhet i vakuum. Produktet oppløses i methanol og hensettes til langsom utkrystallisasjon, hvorved det som hovedkomponent fåes 80,9 mg 17a,20,20,21-bis(methylendioxy)-116-hydroxy-16a-methyl-2'-(p-fluorfenyl)-4-pregnen-(3,2-c)-pyrazol, smeltepunkt 149 - 152° C, X Me?H = 260 (e = 299). and the mixture is heated rapidly to the boiling point. After boiling with reflux for 1 hour, the mixture is evaporated to dryness. The evaporation residue is dissolved in ether, the ether layer is treated 3 times with 2.5 N hydrochloric acid and then 3 times with 2.5 N sodium hydroxide and finally with water. The ether layer is dried over magnesium sulphate, filtered and concentrated to dryness in vacuo. The product is dissolved in methanol and set aside for slow crystallization, whereby 80.9 mg of 17a,20,20,21-bis(methylenedioxy)-116-hydroxy-16a-methyl-2'-(p-fluorophenyl)-4 is obtained as the main component -pregnene-(3,2-c)-pyrazole, melting point 149 - 152° C, X Me?H = 260 (e = 299).
ms. KS etc. KS
Moderluten kromatograferes på nøytralt aluminiumoxyd og elueres derpå med en blanding av benzen og n-hexan, hvorved det fåes ytterligere 44,5 mg produkt, som etter omkrystallisasjon fra methanol smelter ved 147 - 152° C. 70 mg 17a,20,20,21-bis(methylendioxy)-110-hydroxy-16a-methyl-2'-(p-fluorfenyl)-4-pregnen-(3,2-c)-pyrazol oppvarmes på dampbad med 2 ml av en 60 % oppløsning av maursyre i 3 5 minutter. Overskudd av reagens avdestilleres i vakuum under anvendelse av vannbad ved ca. 50° C. Inndampningsresten vaskes omhyggelig med vann og tørres deretter ved 80° C til dannelse av 61,1 mg inndampningsrest. Det urene produkt oppløses i 3 ml spektralren methanol og omsettes med 0,5 ml av en 0,1 N oppløsning av natriummethoxyd i methanol ved romtemperatur i 10 minutter. Produktet, som har en pH-verdi over 11, nøytraliseres med eddiksyre. Blandingen inndampes deretter til tørrhet og vaskes omhyggelig med vann, filtreres og tørkes til konstant vekt, hvorved fåes 57,5 mg 118 »17a,21-trihydroxy-16a-methyl-2 0-oxo-21-(p-fluorfenyl)-4-preg-nen- (3 , 2-c) -pyrazol, som har et absorps jonsmaksimum ved 2 50 m.o. The mother liquor is chromatographed on neutral aluminum oxide and then eluted with a mixture of benzene and n-hexane, whereby a further 44.5 mg of product is obtained, which after recrystallization from methanol melts at 147 - 152° C. 70 mg 17a,20,20,21 -bis(methylenedioxy)-110-hydroxy-16a-methyl-2'-(p-fluorophenyl)-4-pregnene-(3,2-c)-pyrazole is heated on a steam bath with 2 ml of a 60% solution of formic acid in 3 5 minutes. Excess reagent is distilled off in a vacuum using a water bath at approx. 50° C. The evaporation residue is washed carefully with water and then dried at 80° C to form 61.1 mg of evaporation residue. The impure product is dissolved in 3 ml of spectrally pure methanol and reacted with 0.5 ml of a 0.1 N solution of sodium methoxide in methanol at room temperature for 10 minutes. The product, which has a pH value above 11, is neutralized with acetic acid. The mixture is then evaporated to dryness and washed carefully with water, filtered and dried to constant weight, yielding 57.5 mg of 118 »17a,21-trihydroxy-16a-methyl-2 0-oxo-21-(p-fluorophenyl)-4 -preg-nen-(3,2-c)-pyrazole, which has an absorption maximum at 250 m.o.
Ca. 137 mg 118,17a,21-trihydroxy-16a-methyl-20-oxo-2'-(p-fluorfenyl)-4-pregnen-{3,2-c)-pyrazol behandles med en blanding av 4 ml pyridin og 4 ml eddiksyreanhydrid, og blandingen tillates å stå ved romtemperatur i 18 timer. Oppløsningsmidlene avdestilleres i vakuum, inndampningsresten vaskes med små porsjoner benzen. Etter tørking veier den 12 0 mg. Denne rest kromatograferes over silikagel. Fraksjonen som elueres med 8:2 petrolether:ether, omkrystalliseres fra methanol, hvorved fåes 113,17a,21-trihydroxy-16a-methyl-2 0-oxo-2'-(p-fluorfenyl)-4-pregnen-(3,2-c) -pyrazol-21-acetat, med smeltepunkt 178 - 184° C. Etter ytterligere omkrystallisasjon smelter en prøve ved 186 - 188° C. About. 137 mg of 118,17a,21-trihydroxy-16a-methyl-20-oxo-2'-(p-fluorophenyl)-4-pregnene-{3,2-c)-pyrazole is treated with a mixture of 4 ml of pyridine and 4 ml of acetic anhydride, and the mixture is allowed to stand at room temperature for 18 hours. The solvents are distilled off in vacuum, the evaporation residue is washed with small portions of benzene. After drying, it weighs 120 mg. This residue is chromatographed over silica gel. The fraction eluted with 8:2 petroleum ether:ether is recrystallized from methanol, whereby 113,17a,21-trihydroxy-16a-methyl-2 0-oxo-2'-(p-fluorophenyl)-4-pregnene-(3, 2-c)-pyrazole-21-acetate, with melting point 178 - 184° C. After further recrystallization, a sample melts at 186 - 188° C.
Eksempel 8 Example 8
Til 223 mg 17a,20,20,21-bis(methylendioxy)-118-hydroxy-2-hydroxymethylen-16a-methyl-4-pregnen-3-on i 3 ml absolutt ethanol settes 49,2 mg natriumacetat og derpå 10 5 mg p-methoxyfenyl-hydrazin-hydroklorid. Reaksjonsblandingen kokes med tilbakeløps-kjøling i 5 minutter, hvorunder dens farve blir mørk. Produktet frafiltreres og inndampes til tørrhet. Residuet oppløses i ether, oppløsningen filtreres og omrøres med residuets egen vekt av "Darco G-60" (en kvalitet avfarvende trekull). Filtratet inndampes til et volum på 1 ml. Petrolether tilsettes derpå, og produktet frafiltreres, hvorved man får 17a,20,20,21-bis(methylendioxy)-16a-methyl-1'-(p-methoxyfenyl)-(3,2-c)-pyrazol-4-pregnen-llB-ol. To 223 mg of 17a,20,20,21-bis(methylenedioxy)-118-hydroxy-2-hydroxymethylene-16a-methyl-4-pregnen-3-one in 3 ml of absolute ethanol is added 49.2 mg of sodium acetate and then 10 5 mg of p-methoxyphenyl-hydrazine hydrochloride. The reaction mixture is refluxed for 5 minutes, during which time its color becomes dark. The product is filtered off and evaporated to dryness. The residue is dissolved in ether, the solution is filtered and stirred with the residue's own weight of "Darco G-60" (a quality decolorizing charcoal). The filtrate is evaporated to a volume of 1 ml. Petroleum ether is then added, and the product is filtered off, whereby 17a,20,20,21-bis(methylenedioxy)-16a-methyl-1'-(p-methoxyphenyl)-(3,2-c)-pyrazole-4-pregnene is obtained -llB-ol.
I spektrets ultrafiolette område: 268 my, (e = 268). In the ultraviolet region of the spectrum: 268 my, (e = 268).
7 0 mg av dette materiale oppvarmes på dampbad med 7 ml 70 mg of this material is heated on a steam bath with 7 ml
60 % vandig maursyre i ca. 40 minutter under nitrogenatmosfære. Blandingen inndampes til tørrhet, residuet tilsettes vann og produktet frafiltreres. Spekteret i det infrarøde område viser en høy topp ved 5,84 y (C=0) og et maksimum ved 8,15 y. I det ultrafiolette område: X Vo 266 my, (e = 296). 60% aqueous formic acid for approx. 40 minutes under a nitrogen atmosphere. The mixture is evaporated to dryness, the residue is added to water and the product is filtered off. The spectrum in the infrared region shows a high peak at 5.84 y (C=0) and a maximum at 8.15 y. In the ultraviolet range: X Vo 266 my, (e = 296).
niciK s niciK p
50 mg av dette materiale renses ved å oppløse det i aceton og tilsette 50 mg "Nuchar C-1000-N" (en kvalitet avfarvende trekull) til oppløsningen og derpå filtrere denne. Det tilsettes petrolether, og produktet krystalliseres. Etter flere behandlinger får man et gult, fast stoff som består av 113,17a,21-trihydroxy-16a-methyl-l'-(p-methoxyfenyl)-(3,2-c)-pyrazol-4-pregnen-20-on, 50 mg of this material is purified by dissolving it in acetone and adding 50 mg of "Nuchar C-1000-N" (a quality decolorizing charcoal) to the solution and then filtering it. Petroleum ether is added, and the product crystallizes. After several treatments, a yellow solid is obtained consisting of 113,17a,21-trihydroxy-16a-methyl-1'-(p-methoxyphenyl)-(3,2-c)-pyrazole-4-pregnen-20- on
X mak, s 270 my, (e = 338). X mak, p 270 my, (e = 338).
I en alternativ utførelsesform settes 49,2 mg natriumacetat og derpå 10 5 mg p-methoxyfenyl-hydrazin-hydroklorid til 2 33 mg 17a,20,20,21-bis-(methylendioxy)-llB-hydroxy-2-hydroxymethylen-16a-methyl-4-pregnen-3-on, hvorpå man lar blandingen stå ved rom- hvor betegner B-hydroxy eller keto, R2 betegner hydrogen, fluor eller methyl, R 3 betegner a-methyl, $-methyl eller methylen, R^ betegner hydrogen eller acyl, R5 betegner hydrogen, acyl, alkyl, cyclyalkyl, arylalkyl eller en arylgruppe som eventuelt kan være substituert med et halogenatom, en alkylgruppe eller en alkoxy-gruppe, og X betegner hydrogen eller halogen, karakterisert ved at en forbindelse av den generelle formel: hvor <R>1<?> R2, R3 og X har de ovenfor angitte betydninger, omsettes med et alkylformiat og natriumhydrid i inert atmosfære, hvorved det fåes en forbindelse av den generelle formel: temperatur i 5 timer. Den inndampes derpå til tørrhet. Residuet oppløses i ether, og oppløsningen ekstraheres først med en 2,5 N natriumhydroxydoppløsning, derpå med 2,5 N saltsyre, deretter med vann og sluttelig med en mettet natriumkloridoppløsning. Oppløs-ningen i ether befries for vann med magnesiumsulfat, filtreres og inndampes til tørrhet, hvorved man får et residuum som viser et maksimum i spekterets ultrafiolette område ved 270 mp, (e = 258). In an alternative embodiment, 49.2 mg of sodium acetate and then 10 5 mg of p-methoxyphenyl-hydrazine hydrochloride are added to 2 33 mg of 17a,20,20,21-bis-(methylenedioxy)-11B-hydroxy-2-hydroxymethylene-16a- methyl-4-pregnen-3-one, after which the mixture is allowed to stand at room- where denotes B-hydroxy or keto, R2 denotes hydrogen, fluorine or methyl, R 3 denotes a-methyl, $-methyl or methylene, R^ denotes hydrogen or acyl, R5 denotes hydrogen, acyl, alkyl, cyclalkyl, arylalkyl or an aryl group which may optionally be substituted with a halogen atom, an alkyl group or an alkoxy group, and X denotes hydrogen or halogen, characterized in that a compound of the general formula: where <R>1<?> R2, R3 and X have the meanings given above, is reacted with an alkyl formate and sodium hydride in an inert atmosphere, whereby a compound of the general formula is obtained: temperature for 5 hours. It is then evaporated to dryness. The residue is dissolved in ether, and the solution is first extracted with a 2.5 N sodium hydroxide solution, then with 2.5 N hydrochloric acid, then with water and finally with a saturated sodium chloride solution. The solution in ether is freed from water with magnesium sulphate, filtered and evaporated to dryness, whereby a residue is obtained which shows a maximum in the ultraviolet region of the spectrum at 270 mp, (e = 258).
Det således erholdte råprodukt oppløses i 20 ml methanol under oppvarming, og oppløsningen tilsettes 50 g "Nuchar C-1000-N". Blandingen filtreres, og filtratet inndampes til lite volum. Det tilsettes derpå vann, hvorved det utskilles 75 mg 116,17a,21-trihydroxy-16a-methyl-l'-(p-methoxyfenyl)-(3,2-c)-pyra-zol-4-pregnen-20-on, som renses ved kromatografi i silikagel. Spekteret i det ultrafiolette område viser X maks273, (e = 287). The crude product thus obtained is dissolved in 20 ml of methanol while heating, and 50 g of "Nuchar C-1000-N" is added to the solution. The mixture is filtered, and the filtrate is evaporated to a small volume. Water is then added, whereby 75 mg of 116,17a,21-trihydroxy-16a-methyl-1'-(p-methoxyphenyl)-(3,2-c)-pyr-azol-4-pregnen-20-one is separated , which is purified by chromatography in silica gel. The spectrum in the ultraviolet region shows X max 273, (e = 287).
116 j17a,21-trihydroxy-16a-methyl-l'-(p-methoxyfenyl)-(3,2-c)-pyrazol-4-pregnen-20-onet behandles med en blanding av 1,5 ml pyridin og 1,5 ml eddiksyreanhydrid, og man lar blandingen stå natten over ved romtemperatur. Oppløsningsmidlene fjernes derpå i vakuum, residuet tilsettes vann, og det erholdte 116,17a, 21-trihydroxy-16a-methyl-l'-(p-methoxyfenyl)-(3,2-c)-pyrazol-4-pregnen-20-on-21-acetat fraskilles ved filtrering. Etter tørking oppløses forbindelsen i methylenklorid, oppløsningen tilsettes noen få dråper 2,5 N saltsyre, hvorpå den inndampes til tørrhet. Det herved erholdte 118,17a,21-trihydroxy-16a-methyl-l'-(p-methoxyfenyl)-(3 ,2-c)-pyråzol-4-pregnen-20-on-21-acetat-hydroklorid er oppløselig i methylenklorid og kan krystalliseres fra aceton. 116 The 17a,21-trihydroxy-16a-methyl-1'-(p-methoxyphenyl)-(3,2-c)-pyrazol-4-pregnen-20-one is treated with a mixture of 1.5 ml of pyridine and 1, 5 ml of acetic anhydride, and the mixture is left overnight at room temperature. The solvents are then removed in vacuo, the residue is added to water, and the obtained 116,17a, 21-trihydroxy-16a-methyl-1'-(p-methoxyphenyl)-(3,2-c)-pyrazole-4-pregnene-20- on-21-acetate is separated by filtration. After drying, the compound is dissolved in methylene chloride, a few drops of 2.5 N hydrochloric acid are added to the solution, after which it is evaporated to dryness. The 118,17a,21-trihydroxy-16a-methyl-1'-(p-methoxyphenyl)-(3,2-c)-pyrazol-4-pregnen-20-one-21-acetate hydrochloride thus obtained is soluble in methylene chloride and can be crystallized from acetone.
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4466173 | 1973-09-24 | ||
GB44660/73A GB1479597A (en) | 1973-09-24 | 1973-09-24 | Stabilized aqueous catecholamine solutions |
Publications (3)
Publication Number | Publication Date |
---|---|
NO743385L NO743385L (en) | 1975-04-21 |
NO142241B true NO142241B (en) | 1980-04-14 |
NO142241C NO142241C (en) | 1980-07-30 |
Family
ID=26265432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO743385A NO142241C (en) | 1973-09-24 | 1974-09-20 | PROCEDURE FOR PREPARING A STABLE, Aqueous SOLUTION FOR TOPICAL USE OF LIVING TISSUE |
Country Status (9)
Country | Link |
---|---|
CA (1) | CA1027043A (en) |
CH (1) | CH618604A5 (en) |
DE (1) | DE2445270C2 (en) |
DK (1) | DK139658B (en) |
FR (1) | FR2244454B1 (en) |
HU (2) | HU173655B (en) |
NL (1) | NL7412570A (en) |
NO (1) | NO142241C (en) |
SE (1) | SE429494B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008256A (en) * | 1995-08-28 | 1999-12-28 | Showa Yakuhin Kako Co., Ltd. | Composition for local anesthesia |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2070173A1 (en) * | 1969-10-29 | 1971-09-10 | Alcon Lab In | Stabilized aqs pyrocatecholamine prepns |
-
1974
- 1974-09-20 NO NO743385A patent/NO142241C/en unknown
- 1974-09-21 DE DE2445270A patent/DE2445270C2/en not_active Expired
- 1974-09-23 SE SE7411915A patent/SE429494B/en unknown
- 1974-09-23 DK DK498274AA patent/DK139658B/en not_active IP Right Cessation
- 1974-09-23 CA CA209,766A patent/CA1027043A/en not_active Expired
- 1974-09-24 HU HU74SI1586A patent/HU173655B/en unknown
- 1974-09-24 FR FR7432098A patent/FR2244454B1/fr not_active Expired
- 1974-09-24 NL NL7412570A patent/NL7412570A/en not_active Application Discontinuation
- 1974-09-24 HU HU74SI00001431A patent/HU171831B/en unknown
- 1974-09-24 CH CH1288674A patent/CH618604A5/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SE7411915L (en) | 1975-03-25 |
SE429494B (en) | 1983-09-12 |
HU173655B (en) | 1979-07-28 |
NO743385L (en) | 1975-04-21 |
FR2244454A1 (en) | 1975-04-18 |
NL7412570A (en) | 1975-03-26 |
AU7362574A (en) | 1976-04-01 |
CH618604A5 (en) | 1980-08-15 |
HU171831B (en) | 1978-03-28 |
CA1027043A (en) | 1978-02-28 |
DK139658B (en) | 1979-03-26 |
NO142241C (en) | 1980-07-30 |
DE2445270A1 (en) | 1975-04-03 |
FR2244454B1 (en) | 1978-09-22 |
DK498274A (en) | 1975-05-26 |
DK139658C (en) | 1979-09-24 |
DE2445270C2 (en) | 1986-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0100874B1 (en) | 6,16-dimethyl corticoids, their preparation and their use | |
NO162665B (en) | PROCEDURE FOR THE PREPARATION OF HIGH PURITY OF ORDEXOXYCHOLIC ACID. | |
NO143159B (en) | PROCEDURE FOR THE PREPARATION OF METHYLMETACRYLATE-ALKYLACRYLATE COPOLYMERS. | |
NO143349B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF DAUNORUBICIN | |
NO142241B (en) | PROCEDURE FOR PREPARING A STABLE, Aqueous SOLUTION FOR TOPICAL USE OF LIVING TISSUE | |
Oliveto et al. | The Formation of Ketals from Steroid Ketones with Selenium Dioxide and Methanol | |
NO122525B (en) | ||
US3133940A (en) | Process for the separation of delta-1, 4-3-keto steroid compounds from mixtures thereof with other 3-keto steroids | |
NO149353B (en) | PROCEDURE FOR PREPARING 6-CHLORO-ALFA-METHYL CARBZOL-2-ACETIC ACID | |
EP1819705A1 (en) | Method for preparing hexahydro-8-hydroxy-2,6-methano-2h-chinolizin-3(4h)-one esters | |
FI70027B (en) | FREQUENCY REQUIREMENT FOR THERAPEUTIC USE OF THERAPEUTIC 1819-DINORPREGN-4-EN-3,20-DIONER | |
US4331663A (en) | 4α,5α-Epoxy-3,20-dioxopregnane-2α,16α-dicarbonitrile and intermediates and process for preparation, method of use and compositions thereof | |
NO134990B (en) | ||
Pataki et al. | Synthesis of fluorinated 3β-hydroxypregn-5-en-20-one derivatives | |
NO134604B (en) | ||
DE1668205C3 (en) | 16 alpha-alkylthio-9beta, lOalpha steroids, processes for their preparation and pharmaceutical preparations containing them | |
Reusch et al. | Steroid Epoxy Ketones. II. 2, 3-Oxygenated Steroids from 1α, 2α-Oxidocholestan-3-one | |
EP0164298A2 (en) | 6-Alpha-methyl-D-homo-corticoids | |
SU717064A1 (en) | Method of preparing 16-alpha,17-alpha-disubstituted pregnanes | |
JPS6039278B2 (en) | steroid derivatives | |
NO154276B (en) | DEVICE FOR FOAMS OF FLOATING SUBSTANCES. | |
MORI et al. | Studies on Cardiac Ingredients of Plants. V.: Chemical Transformation of Proscillaridin and Biological Activities of Derivaties | |
RU2129125C1 (en) | METHOD OF SYNTHESIS OF 13α-TRIENE-19-NORANDROSTANE-3-OL-17-ONE AND ITS METHYL ESTER | |
IL34053A (en) | 6alpha,9alpha,11beta,21-tetrahalo steroids of the pregnane series | |
DE2138426A1 (en) | New steroids and methods of making them |